Back to Search
CHARLES BLANKE, MD
MD
Medical Oncology Physician
NPI: 1639187198IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD21402(OR)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
NORTHWESTERN UNIVERSITY FEINBERG MEDICAL SCHOOL
Class of 1988
Research & Publications (20)
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
PMID 18235121·J Clin Oncol·2008
3-trial
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
PMID 18235122·J Clin Oncol·2008
3-trial
A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer.
PMID 15789623·Prostaglandins Other Lipid Mediat·2005
3-trial
State-of-the art therapy for gastrointestinal stromal tumors.
PMID 15945512·Cancer Invest·2005
6-review
Low dose versus high dose imatinib for gastrointestinal stromal tumors.
PMID 16265122·Nat Clin Pract Gastroenterol Hepatol·2005
8-other
Chemotherapy with cyclooxygenase-2 inhibitors in the treatment of malignant disease: pre-clinical rationale and preliminary results of clinical trials.
PMID 12795058·Prog Exp Tumor Res·2003
6-review
A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer.
PMID 11863117·Ann Oncol·2002
3-trial
Celecoxib with chemotherapy in colorectal cancer.
PMID 12014863·Oncology (Williston Park)·2002
6-review
A phase I study of vitamin E, 5-fluorouracil and leucovorin for advanced malignancies.
PMID 11291830·Invest New Drugs·2001
3-trial
A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with previously untreated gastric adenocarcinoma.
PMID 11822757·Ann Oncol·2001
3-trial
Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.
PMID 19509180·Clin Cancer Res·2009
8-other
Perioperative treatment of gastrointestinal stromal tumors.
PMID 19283922·Oncology (Williston Park)·2009
6-review
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
PMID 19303137·Lancet·2009
3-trial
Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.
PMID 19451435·J Clin Oncol·2009
3-trial
Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor.
PMID 19671739·Mol Cancer Ther·2009
3-trial
Dual-antibody therapy in advanced colorectal cancer: gather ye rosebuds while ye may.
PMID 19114682·J Clin Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD, MAILCODE L586
PORTLAND, OR 97239 - Phone
- (503) 494-1556
Quick Facts
- NPI
- 1639187198
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile